(Reuters) – Keros Therapeutics said on Wednesday it would voluntarily halt testing of its experimental hypertension treatment due to safety concerns during a mid-stage trial.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
Keros halts hypertension treatment trial on safety issues
Jan 15, 2025 | 6:55 AM
On Air Now
Wed Nov 4
Holland, MI, USA
63°FWind/Dir: 48 MPH-S
Humidity: 94%
Our Playlist
Comments